Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/7214
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJoksic, I-
dc.contributor.authorVujic, D-
dc.contributor.authorGuc-Scekic, M-
dc.contributor.authorLeskovac, A-
dc.contributor.authorPetrovic, S-
dc.contributor.authorOjani, M-
dc.contributor.authorTrujillo, JP-
dc.contributor.authorSurralles, J-
dc.contributor.authorZivkovic, M-
dc.contributor.authorStankovic, A-
dc.contributor.authorSlijepcevic, P-
dc.contributor.authorJoksic, G-
dc.date.accessioned2013-02-08T15:24:05Z-
dc.date.available2013-02-08T15:24:05Z-
dc.date.issued2012-
dc.identifier.citationStem Cell Research and Therapy, 3(6), Sep 2012en_US
dc.identifier.issn1757-6512-
dc.identifier.urihttp://www.genomeintegrity.com/content/3/1/6en
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/7214-
dc.description© 2012 Joksic et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
dc.descriptionThis article has been made available through the Brunel Open Access Publishing Fund.-
dc.description.abstractBackground: Fanconi anemia (FA) is characterized by sensitivity to DNA cross-linking agents, mild cellular, and marked clinical radio sensitivity. In this study we investigated telomeric abnormalities of non-immortalized primary cells (lymphocytes and fibroblasts) derived from FA patients of the FA-D2 complementation group, which provides a more accurate physiological assessment than is possible with transformed cells or animal models. Results: We analyzed telomere length, telomere dysfunction-induced foci (TIFs), sister chromatid exchanges (SCE), telomere sister chromatid exchanges (T-SCE), apoptosis and expression of shelterin components TRF1 and TRF2. FANCD2 lymphocytes exhibited multiple types of telomeric abnormalities, including premature telomere shortening, increase in telomeric recombination and aberrant telomeric structures ranging from fragile to long-string extended telomeres. The baseline incidence of SCE in FANCD2 lymphocytes was reduced when compared to control, but in response to diepoxybutane (DEB) the 2-fold higher rate of SCE was observed. In contrast, control lymphocytes showed decreased SCE incidence in response to DEB treatment. FANCD2 fibroblasts revealed a high percentage of TIFs, decreased expression of TRF1 and invariable expression of TRF2. The percentage of TIFs inversely correlated with telomere length, emphasizing that telomere shortening is the major reason for the loss of telomere capping function. Upon irradiation, a significant decrease of TIFs was observed at all recovery times. Surprisingly, a considerable percentage of TIF positive cells disappeared at the same time when incidence of γ-H2AX foci was maximal. Both FANCD2 leucocytes and fibroblasts appeared to die spontaneously at higher rate than control. This trend was more evident upon irradiation; the percentage of leucocytes underwent apoptosis was 2.59- fold higher than that in control, while fibroblasts exhibited a 2- h delay before entering apoptosis. Conclusion: The results of our study showed that primary cells originating from FA-D2 patients display shorten telomeres, elevated incidence of T-SCEs and high frequency of TIFs. Disappearance of TIFs in early response to irradiation represent distinctive feature of FANCD2 cells that should be examined further.en_US
dc.description.sponsorshipThis article is made available through the Brunel Open Access Publishing Fund. This work was supported by the Ministry of Education and Science of the Republic of Serbia (Project No.173046).en_US
dc.language.isoenen_US
dc.publisherBioMed Central Ltden_US
dc.subjectPrimary FA cellsen_US
dc.subjectTelomere dysfunctionen_US
dc.subjectExpression of TRF1 and TRF2en_US
dc.titleDysfunctional telomeres in primary cells from Fanconi anemia FANCD2 patientsen_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.1186/2041-9414-3-6-
pubs.organisational-data/Brunel-
pubs.organisational-data/Brunel/Brunel Active Staff-
pubs.organisational-data/Brunel/Brunel Active Staff/School of Health Sciences & Social Care-
pubs.organisational-data/Brunel/Brunel Active Staff/School of Health Sciences & Social Care/Biological Sciences-
pubs.organisational-data/Brunel/University Research Centres and Groups-
pubs.organisational-data/Brunel/University Research Centres and Groups/School of Health Sciences and Social Care - URCs and Groups-
pubs.organisational-data/Brunel/University Research Centres and Groups/School of Health Sciences and Social Care - URCs and Groups/Brunel Institute for Ageing Studies-
pubs.organisational-data/Brunel/University Research Centres and Groups/School of Health Sciences and Social Care - URCs and Groups/Brunel Institute of Cancer Genetics and Pharmacogenomics-
Appears in Collections:Biological Sciences
Publications
Brunel OA Publishing Fund
Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf1.09 MBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.